Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM)
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F18%3A43916952" target="_blank" >RIV/00216208:11120/18:43916952 - isvavai.cz</a>
Alternative codes found
RIV/67985807:_____/18:00492077 RIV/68407700:21730/18:00327615 RIV/00216208:11130/18:10381182 RIV/00064203:_____/18:10381182
Result on the web
<a href="https://doi.org/10.1007/s13300-018-0485-2" target="_blank" >https://doi.org/10.1007/s13300-018-0485-2</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s13300-018-0485-2" target="_blank" >10.1007/s13300-018-0485-2</a>
Alternative languages
Result language
angličtina
Original language name
Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM)
Original language description
INTRODUCTION: The aim of the study was to determine the level of metabolic control in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) patients in the Czech and Slovak Republics. METHODS: A non-interventional prospective (observational) study was conducted from January 2015 until April 2016 in routine clinical practice settings at 141 centers in the Czech and Slovak Republics. Data were analyzed from a total of 425 patients with T1DM and 1034 patients with T2DM, proportionally corresponding to the number of patients in both countries. The primary objective of the study was to determine the percentage of patients with HbA1c < 7% (53 mmol/mol). RESULTS: Patients with T1DM: In this group of patients (55.8% males, mean age 45.9 +- 14.83 years, BMI 25.8 +- 4.21 kg/m2, diabetes duration 12.1 +- 9.44 years), 29.9% reached HbA1c levels < 53 mmol/mol. Patients with T2DM: In this group of patients (50.3% male, mean age 63.9 +- 9.65 years, BMI 31.0 +- 5.19 kg/m2, diabetes duration 12.4 +- 7.47 years, duration of insulin therapy 5.8 +- 4.71 years), 33.4% reached HbA1c levels < 53 mmol/mol. CONCLUSION: The overall percentage of patients with HbA1c < 53 mmol/mol in the T1DM group was 29.9% and in the T2DM group was 33.4%. Despite an increasing number of treatment options, most patients still fail to reach the recommended HbA1c targets.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30202 - Endocrinology and metabolism (including diabetes, hormones)
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Diabetes Therapy
ISSN
1869-6953
e-ISSN
—
Volume of the periodical
9
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
10
Pages from-to
1897-1906
UT code for WoS article
000446637300013
EID of the result in the Scopus database
2-s2.0-85054135878